Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

So we have further in vivo study. Good to see- In an A. fumigatus immunosuppressed mouse model in invasive pulmonary aspergillosis, Brilacidin plus CAS cleared infection in the lungs by almost 95 percent, compared to ~50 percent when each compound was administered individually.

So far..
Anti-viral nasal in vivo
Anti-fungal in vivo

Moving on up as they say.